Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Pancreatic Cancer
2 articles
Epigenetic-Immunotherapy Combo Shows Promise in Advanced Pancreatic Cancer
Phase 2 trial combines HDAC inhibitor and PD-1 inhibitor in pancreatic cancer, showing durable responses.
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.